Keyphrases
Herpes Simplex Virus 2 (HSV-2)
100%
Potential Therapeutics
100%
Genital Herpes Simplex Virus
100%
Immunomodulating
100%
Dipeptide
100%
Recurrent Genital Herpes
100%
Recurrent Lesions
75%
Recurrent Disease
50%
Treatment Options
25%
Therapeutic Strategies
25%
Guinea pig
25%
Herpes Simplex Virus Type 2 Infection
25%
Therapeutic Potential
25%
Disease States
25%
AIDS/HIV
25%
Drug Resistance
25%
Guinea pig Model
25%
Therapeutic Treatment
25%
Oral Dose
25%
Tryptophan
25%
Overnight Fast
25%
Antimicrobial Activity
25%
Current Therapeutics
25%
Treatment Cessation
25%
Immunomodulatory Activity
25%
Lesion Formation
25%
Dose-ranging Study
25%
Aciclovir
25%
Pharmacology, Toxicology and Pharmaceutical Science
Herpes Simplex Virus 2
100%
Genital Herpes
100%
Dipeptide
100%
Recurrent Disease
40%
Infection
20%
Guinea Pig
20%
HIV
20%
Infectious Agent
20%
Drug Resistance
20%
Guinea Pig Model
20%
Aciclovir
20%
Tryptophan
20%
Immunoglobulin D
20%
Antimicrobial Agent
20%
Immunology and Microbiology
Herpes Simplex Virus 2
100%
Genital Herpes
100%
Human Immunodeficiency Virus
20%
Infectious Agent
20%
Guinea Pig
20%
Drug Resistance
20%
Guinea Pig Model
20%
Antimicrobial Activity
20%
Immunoglobulin D
20%
Antimicrobial Agent
20%
Neuroscience
Herpes Simplex Virus
100%
Dipeptide
100%
Human Immunodeficiency Virus
20%
Tryptophan
20%
Aciclovir
20%
Drug Resistance
20%
Immunoglobulin D
20%
Antimicrobial Agent
20%